Association between tenofovir plasma trough concentrations in the early stage of administration and discontinuation of up to five years tenofovir disoproxil fumarate due to renal function-related adverse events in Japanese HIV-1 infected patients

• Үндсэн зохиолчид: Hiroki Yagura (Зохиогч), Dai Watanabe (Зохиогч), Takao Nakauchi (Зохиогч), Hiroyuki Kushida (Зохиогч), Kazuyuki Hirota (Зохиогч), Yasuharu Nishida (Зохиогч), Munehiro Yoshino (Зохиогч), Tomoko Uehira (Зохиогч), Takuma Shirasaka (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2024-05-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background The relationship between plasma tenofovir (TFV) concentration at the beginning of tenofovir disoproxil fumarate (TDF) administration and the development of renal dysfunction during long-term administration of TDF has not been demonstrated yet. The objective of the present study w...